대화제약: directors' dealings · South Korea · DART (FSS)

Explore the full management transaction log of 대화제약, a listed equity based in South Korea. Shares are quoted on KR KR, under the authority of DART (FSS). Operating in the Healthcare sector, 대화제약 has recorded 5 insider filings. Market capitalisation: €237.4bn. The latest transaction was disclosed on 14 May 2026 (Purchase). Among the most active insiders: 김은석. All data is openly available.